Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIIB
DXCM
Add up to 3 more stocks
BIIB
Biogen Inc.
+0.80%
$217.15+1.72Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$32.08B
52W Range
$135.39 - $225.80
DXCM
DexCom, Inc.
-1.75%
$83.03-1.48Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$31.33B
52W Range
$54.11 - $92.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 38.43 | 32.82 |
| Forward P/E | 17.39 | 31.13 |
| P/B Ratio | 1.70 | 11.95 |
| P/S Ratio | 3.23 | 6.31 |
| P/FCF Ratio | 11.90 | 22.30 |
| EV/EBITDA | N/A | 22.54 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 67.7% | 62.5% |
| Operating Margin | 12.8% | 22.9% |
| Net Margin | 8.4% | 20.1% |
| ROE | 4.4% | 38.1% |
| ROA | 2.6% | 15.5% |
| ROIC | 4.3% | 21.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.87 | 1.73 |
| Quick Ratio | 1.26 | 1.43 |
| Debt/Equity | 0.44 | 0.53 |
| Interest Coverage | 7.63 | 49.83 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.